← Open Payments lookup

ROBERT GREENLEE: Open Payments

NPI 1710401575 · KOSCIUSKO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$275 in 17 payments from 6 companies in 2025. Trend: 2023 $740 · 2024 $870 · 2025 $275

Food & beverage: $275
CompanyPaymentsAmount
Novo Nordisk Inc6$103
ABBVIE INC.4$65
AstraZeneca Pharmaceuticals LP3$48
PFIZER INC.2$28
Averitas Pharma Inc.1$18
Amgen Inc.1$14

Products named: Ozempic, Rybelsus, UBRELVY, FARXIGA, NURTEC ODT, QUTENZA, BREZTRI, CREON.

Industry payments across MS — which companies pay providers there.